Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability

The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023, a bipartisan insulin affordability bill. Introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME), this legislation would cap out-of-pocket insulin costs for those with private insurance, ensure patients can share in insulin rebates and discounts, […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article